KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInvested CapitalNet Margin

National Health Investors (NHI) EBITDA Margin (2016 - 2022)

National Health Investors filings provide 14 years of EBITDA Margin readings, the most recent being 11.56% for Q1 2022.

  • On a quarterly basis, EBITDA Margin fell 3438.0% to 11.56% in Q1 2022 year-over-year; TTM through Mar 2022 was 158.53%, a 21835.0% decrease, with the full-year FY2019 number at 92.55%, down 95.0% from a year prior.
  • EBITDA Margin hit 11.56% in Q1 2022 for National Health Investors, down from 55.13% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 78.93% in Q3 2018 to a low of 11.56% in Q1 2022.
  • Median EBITDA Margin over the past 5 years was 54.44% (2020), compared with a mean of 53.26%.
  • Biggest five-year swings in EBITDA Margin: soared 1741bps in 2020 and later tumbled -3438bps in 2022.
  • National Health Investors' EBITDA Margin stood at 78.93% in 2018, then dropped by -3bps to 76.46% in 2019, then dropped by -29bps to 54.44% in 2020, then increased by 1bps to 55.13% in 2021, then crashed by -79bps to 11.56% in 2022.
  • The last three reported values for EBITDA Margin were 11.56% (Q1 2022), 55.13% (Q2 2021), and 45.94% (Q1 2021) per Business Quant data.